ImmunityBio, Inc.IBRXNASDAQ
LOADING
|||
Operating Income Contraction
Below historical average, modest growth trend.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-344.18M
↓ 54% below average
Average (9y)
$-223.67M
Historical baseline
Range
High:$-66.91M
Low:$-362.25M
CAGR
+4.1%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-344.18M | +5.0% |
| 2023 | $-362.25M | -3.1% |
| 2022 | $-351.30M | -6.4% |
| 2021 | $-330.28M | -49.5% |
| 2020 | $-220.88M | -230.1% |
| 2019 | $-66.91M | +32.0% |
| 2018 | $-98.39M | +0.7% |
| 2017 | $-99.12M | +20.4% |
| 2016 | $-124.50M | +47.9% |
| 2015 | $-238.88M | - |